Consider this. In a recent article on the topic of ‘Inclusion and Diversity in Clinical Trials’, the authors noted that, of the 32,000 individuals who participated in new drug trials in 2020 ...
IQVIA's research has been helped by a "dramatic increase" in diversity data collection in phase 2 and 3 trials in the past six years, which has provided a baseline against which progress can be ...
The pharmaceutical industry is undergoing a transformative shift, recognising the critical importance of diversity in clinical trials. Ensuring that research findings are applicable and beneficial to ...